GEITH SHAHOUD: Open Payments
NPI 1346229291 · GRINDSTONE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,839 in 184 payments from 13 companies in 2025. Trend: 2023 $397 · 2024 $727 · 2025 $2,839
Food & beverage: $2,839
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 82 | $1,009 |
| Vanda Pharmaceuticals Inc. | 19 | $428 |
| Teva Pharmaceuticals USA, Inc. | 11 | $222 |
| Neurocrine BioSciences, Inc. | 15 | $208 |
| Otsuka America Pharmaceutical, Inc. | 10 | $179 |
| Alkermes, Inc. | 12 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $168 |
| Lundbeck LLC | 10 | $159 |
| Janssen Pharmaceuticals, Inc | 8 | $154 |
| Supernus Pharmaceuticals, Inc. | 3 | $55 |
Products named: VRAYLAR, REXULTI, FANAPT, INGREZZA, HETLIOZ, ARISTADA, CAPLYTA, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
